Eli Lilly Announces World's First Potential COVID-19 Antibody Treatment Study
Eli Lilly and Company has begun what it calls the first study in the world for a potential COVID-19 antibody treatment for humans.
Eli Lilly and Company has begun what it calls the first study in the world for a potential COVID-19 antibody treatment for humans.